https://doi.org/10.55788/206ceca0
Mucus dysfunction is a central pathophysiologic feature of COPD that is measurable on CT and is associated with lung function impairment. The COPDGene study (NCT00608764) aimed to assess whether airway mucus plugs detected on CT are associated with mortality in smokers with COPD [1]. The study observed 4,363 participants with COPD who were smokers and had CT images with mucus plugs scored. Dr Alejandro Diaz (Brigham and Womenās Hospital, MA, USA) presented the data.
With a median follow-up of 8.5 years, 1,490 patients had died (34%). A Kaplan-Meier analysis revealed that a high airway mucus plug score was associated with a higher risk of all-cause mortality (see Figure). Similarly, the mucus plug score was associated with a higher risk of respiratory and cancer deaths.
Figure: High airway mucus plug scores are associated with a higher risk of all-cause mortality [1]
Dr Diaz concluded that āthe findings support airway mucus plugs as a clinically relevant imaging biomarker.ā
- Diaz A, et al. Airway Mucus Plugs and Mortality in COPD: Findings from the COPDGene Study. Session D14, ATS International Conference 2022, San Francisco, CA, USA, 13ā18 May.
Copyright Ā©2022 Medicom Medical Publishers
Posted on
Previous Article
« Home-based rehabilitation improves COPD: a randomised study Next Article
Reducing dyspnoea in chronic lung disease through weight loss »
« Home-based rehabilitation improves COPD: a randomised study Next Article
Reducing dyspnoea in chronic lung disease through weight loss »
Table of Contents: ATS 2022
Featured articles
Letter from the Editor
COVID-19
Nebulised aviptadil āfutileā in I-SPY COVID-19 trial
Lung transplantation after COVID-19-associated ARDS
Mesenchymal stem cells offer no benefit in COVID-19
Alpha-1 antitrypsin for ARDS secondary to severe COVID-19
Frailty prevalent 5 months following hospitalisation for COVID-19
Paediatric long COVID lacks definitions
Asthma Clinical Trial Updates
MANDALA and DENALI pattern success for albuterol-budesonide in asthma
ACOUSTICS data sounds good for adolescent asthma exacerbations
Type 2 asthma in children managed by dupilumab, despite atopic comorbidities
NAVIGATOR steers asthma patients to tezepelumab
High-intensity interval training slashes daily corticosteroids in asthma
Chronic Obstructive Pulmonary Disease
Threeās a crowd for triple therapy in COPD
Higher 1-year COPD mortality after hospitalisation for White patients
Reducing dyspnoea in chronic lung disease through weight loss
CT-evident mucus plugs in COPD associated with death
Home-based rehabilitation improves COPD: a randomised study
Highlighted Advances
Novel P2X3 antagonist can SOOTHE chronic cough
Colistimethate sodium PROMISing for non-cystic fibrosis bronchiectasis
Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?
PAGANINI phase 2b data promising for eliapixant
POISE-3: Tranexamic acid for non-cardiac surgery
Obstructive sleep apnoea in most children with pulmonary hypertension
No screening evidence for COPD
Novel PDE4B inhibitor offers breakthrough for IPF
Hydrocortisone does not help preterm infants
CPAP temporarily supports pulmonary oxygenation in morbidly obese patients
ISAACC trial: CPAP controls blood pressure in ACS patients with severe OSA
Related Articles
October 30, 2022
In the spotlight: Cancer trends in obstructive sleep apnoea
October 29, 2020
CPAP withdrawal has negative consequences for sleep apnoea patients
Ā© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com